Abstract We find that variation in the dbt-1 gene underlies natural differences in Caenorhabditis elegans responses to the toxin arsenic. This gene encodes the E2 subunit of the branched-chain aketo acid dehydrogenase (BCKDH) complex, a core component of branched-chain amino acid (BCAA) metabolism. We causally linked a non-synonymous variant in the conserved lipoyl domain of DBT-1 to differential arsenic responses. Using targeted metabolomics and chemical supplementation, we demonstrate that differences in responses to arsenic are caused by variation in iso-branched chain fatty acids. Additionally, we show that levels of branched chain fatty acids in human cells are perturbed by arsenic treatment. This finding has broad implications for arsenic toxicity and for arsenic-focused chemotherapeutics across human populations. Our study implicates the BCKDH complex and BCAA metabolism in arsenic responses, demonstrating the power of C. elegans natural genetic diversity to identify novel mechanisms by which environmental toxins affect organismal physiology. Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review.
Introduction
An estimated 100 million people are currently at risk of chronic exposure to arsenic, a toxic metalloid that can be found in the environment (Ravenscroft et al., 2009) . The high prevalence of environmental arsenic and the severe toxicity associated with exposure has made it the number one priority for the United States Agency for Toxic Substances and Disease Registry (https://www.atsdr.cdc.gov/ SPL/). Inorganic trivalent arsenic As(III) compounds, which include arsenic trioxide (As 2 O 3 ), are the most toxic forms of environmental arsenic (Ratnaike, 2003; Mandal and Suzuki, 2002) . In humans, As(III) is detoxified by consecutive methylation events, forming dimethylarsenite (DMA) (Khairul et al., 2017; Stýblo et al., 2002) . However, this methylation process also creates the highly toxic monomethylarsenite (MMA) intermediate, so ratios of DMA to MMA determine levels of arsenic toxicity. Both MMA and DMA are produced from As(III) via the arsenic methyltransferase (AS3MT) (Schlebusch et al., 2015) . Interestingly, individuals from human subpopulations that inhabit high arsenic environments have higher DMA/MMA ratios than individuals from low-arsenic environments. The elevated DMA/MMA ratio in these individuals is associated with natural differences in the AS3MT gene (Chung et al., 2009; Fujihara et al., 2009; Gomez-Rubio et al., 2010) , which shows signs of strong positive selection. These results suggest that a more active AS3MT enzyme in these human subpopulations makes more DMA and enables adaptation to elevated environmental arsenic levels (Schlebusch et al., 2015) . Importantly, population-wide differences in responses to environmental arsenic cannot be explained solely by variation in AS3MT, indicating that other genes must impact arsenic toxicity.
Despite its toxicity, arsenic trioxide has been used as a therapeutic agent for hundreds of years. Most recently, it was introduced as a highly effective cancer chemotherapeutic for the treatment of acute promyelocytic leukemia (APL) (Chen et al., 1997; Antman, 2001; Murgo, 2001; Emi, 2017) . Hematopoietic differentiation and apoptosis in APL patients is blocked at the level of promyelocytes by the Promyelocytic Leukemia/Retinoic Acid Receptor alpha fusion protein caused by a t(15;17) chromosomal translocation (de Thé et al., 1990; Grignani et al., 2000) . Arsenic trioxide has been shown to directly bind a cysteine-rich region of the RING-B box coiled-coil domain of PML-RARa, which causes the degradation of the oncogenic fusion protein (Zhang et al., 2010; Tomita et al., 2013) . The success of arsenic trioxide (Trisenox) has spurred its use in over a hundred clinical trials in the past decade (Hoonjan et al., 2018) . Despite these successes, individual differences in the responses to arsenic-based treatments, including patient-specific dosing regimens and side effects, limit the full therapeutic benefit of this compound (Zeidan and Gore, 2014) . Medical practitioners require knowledge of the molecular mechanisms for how arsenic causes toxicity to provide the best individual-based therapeutic benefits.
Studies of the free-living roundworm Caenorhabditis elegans have greatly facilitated our understanding of basic cellular processes (Kniazeva et al., 2004; Luz et al., 2017; Spracklin et al., 2017; Watson et al., 2013) , including a number of studies that show that the effects of arsenic are similar to what is observed in mammalian model systems and humans. These effects include mitochondrial toxicity , the generation of reactive oxygen species (ROS) (Schmeisser et al., 2013) , genotoxicity (Wyatt et al., 2017) , genome-wide shifts in chromatin structure (Large et al., 2016) , reduced lifespan (Schmeisser et al., 2013) , and the induction of the heatshock response . However, these studies were all performed in the genetic background of the standard C. elegans laboratory strain (N2). To date, 152 C. elegans strains have been isolated from various locations around the world (Andersen et al., 2012; Cook et al., 2016; Cook et al., 2017) , which contain a largely unexplored pool of genetic diversity much of which could underlie adaptive responses to environmental perturbations .
We used two quantitative genetic mapping approaches to show that a major source of variation in C. elegans responses to arsenic trioxide is caused by natural variation in the dbt-1 gene, which encodes an essential component of the highly conserved branched-chain a-keto acid dehydrogenase (BCKDH) complex (Jia et al., 2016) . The BCKDH complex is a core component of branched-chain amino acid (BCAA) catabolism, which has not been previously implicated in arsenic responses. Furthermore, we show that a single missense variant in DBT-1(S78C), located in the highly conserved lipoyl-binding domain, underlies phenotypic variation in response to arsenic. Using targeted and untargeted metabolomics and chemical rescue experiments, we show that differences in wild isolate responses to arsenic trioxide are caused by differential synthesis of mono-methyl branched chain fatty acids (mmBCFA), metabolites with a central role in development (Kniazeva et al., 2004 ). These results demonstrate the power of using the natural genetic diversity across the C. elegans species to identify mechanisms by which environmental toxins affect physiology.
Results

Natural variation on chromosome II underlies differences in arsenic responses
We quantified arsenic trioxide sensitivity in C. elegans using a high-throughput fitness assay that utilizes the COPAS BIOSORT . In this assay, three L4 larvae from each strain were sorted into arsenic trioxide or control conditions. After four days of growth, we quantified various attributes of populations that relate to the ability of C. elegans to grow in the presence of arsenic trioxide or control conditions (see Materials and methods). To determine an appropriate concentration of arsenic trioxide for mapping experiments, we performed dose-response experiments on four genetically diverged isolates of C. elegans: N2, CB4856, JU775, and DL238 (Figure 1-figure supplement 1; Figure 1 -figure supplement 1-source data 1). To assess arsenic-induced toxicity, we studied four independently measured traits: brood size, animal length, optical density, and fluorescence (see Materials and methods) . When compared to control conditions, all four strains produced fewer progeny at all arsenic trioxide concentrations, and the lowest concentration at which we observed a significant reduction in brood size for all strains was 1 mM (Figure 1-figure supplement 1A) . We used statistical summaries of measurements of individual animals as replicated identical genotypes to estimate broad-sense heritability (H 2 ) across the four strains, but this analysis might not represent the effects of arsenic on individuals within natural populations. For the brood size trait in 1 mM arsenic trioxide, we calculated H 2 to be 0.65 (Figure 1-fig- ure supplement 3-source data 1) and the strain effect to be 0.48 (partial omega squared, ! 2 p , Figure 1 -figure supplement 3-source data 2), indicating that this trait has a large genetic component and a large strain effect. In addition to brood size effects, we observed that the progeny of animals exposed to arsenic trioxide were shorter in length than the progeny of animals grown in control conditions (Figure 1-figure supplement 1B) , which indicates an arsenic-induced developmental delay (animal length (mean.TOF) H 2 = 0.13; Figure 1 -figure supplement 3-source data 1 and Figure 1 -figure supplement 3-source data 2). As C. elegans develop, the animals increase in optical density. Therefore, it is not surprising that we found an arsenic-induced decrease in optical density of progeny populations, which is further support for an arsenic-induced developmental delay ( Figure 1 -figure supplement 3-source data 2). Overall, the CB4856 strain was less affected by arsenic -that strain produced approximately 16% more offspring that were on average 20% larger than the other three strains when treated with 1 mM arsenic trioxide. These results suggest that the CB4856 strain was more resistant to arsenic trioxide than the other three strains. In addition to the BIOSORT-quantified traits, we generated a synthetic principal component (PC) trait using the four quantified traits described above (see Materials and methods, Figure 1 -source data 1), suggesting that PC1 is a biologically relevant trait (Figure 1-figure supplement 1E) . Furthermore, because we observe a large range of effect sizes and broad-sense heritability estimates across measured traits (Figure 1-figure  supplement 3) , we focused our analyses on the PC1 trait derived from the four BIOSORT-quantified described above for all subsequent experiments (Materials and methods).
The increased arsenic trioxide resistance of CB4856 compared to N2 motivated us to perform linkage mapping experiments with a panel of recombinant inbred advanced intercross lines (RIAILs) that were previously constructed through ten generations of intercrossing between an N2 derivative (QX1430) and CB4856 . To capture arsenic trioxide-induced phenotypic differences, we exposed a panel of 252 RIAILs to 1 mM arsenic trioxide and corrected for growth differences among RIAILs in control conditions and assay-to-assay variability using linear regression (Figure 1-source data 2; see Materials and methods). We performed linkage mapping on processed traits and the eigenvector-transformed traits (principal components or PCs) obtained from PCA that explained 90% of the variance in the processed trait set (Materials and methods). The rationale of this approach was to minimize trait fluctuations that could be caused by only measuring the phenotypes of one replicate per RIAIL strain, and PC1 captured overall arsenic-induced toxicity. In agreement with our observations from the dose-response experiment, we found that PC1 captures 69.5% of the total measured trait variance and is strongly influenced by animal length traits ( ). An additional quantitative trait locus (QTL) was significantly associated with variation in arsenic responses on chromosome X (Figure 1-figure supplement 4) . Consistent with the loadings of PC1, we determined that PC1 is highly correlated with the both brood size and animal length traits ( Figure 1B) , suggesting that PC1 captures RIAIL variation in these traits. To further support this relationship to interpretable biological significance, we found that the four traits used as input for PCA all map to the same region on the center of chromosome II (Figure 1-figure supplement 5 ; Figure 1-source data 3) . The QTL on the center of chromosome II explains 35.4% of the total RIAIL phenotypic variation for the PC1 trait, which accounts for 63.4% of the total phenotypic variation that can be explained by genetic factors (H 2 = 0.56) (Figure 1 -figure supplement 6; Figure 1-figure supplement 6-source data 1). Taken together, the two QTL identified by mapping the PC1 trait account for 40% of the total RIAIL variation, corresponding to 71.6% of the total phenotypic variation that can be explained by genetic factors. However, we did not account for errors in genomic heritability estimates. In addition to the two QTL that explain variation of the PC1 trait, we identified a QTL on chromosome I for the brood size and optical density traits, and a QTL on chromosome V that explained variation in animal length and optical density upon arsenic exposure ( However, each of these QTL confidence intervals span genomic regions greater than 1.5 megabases and contain hundreds of genes that vary between the N2 and CB4856 strains.
Next, we constructed near-isogenic lines (NILs) to isolate and narrow the chromosome II QTL in a controlled genetic background. We introgressed genomic regions from the CB4856 strain on the left and right halves of the confidence interval into the N2 genetic background. In the presence of arsenic trioxide, both of these NILs recapitulated the parental CB4856 PC1 phenotype ( Figure 1C ; Figure 1 -figure supplement 9-source data 2). Furthermore, the PC1 trait was highly correlated with the four input traits (Figure 1-figure supplement 10) . The phenotypic similarity of these NILs to the CB4856 parental strain suggested that the two NILs might share an introgressed region of the CB4856 genome. To identify this shared introgressed region, we performed low-coverage whole-genome sequencing of the NIL strains and defined the left and right bounds of the CB4856 genomic introgression to be from 5.75 to 8.02 Mb and 7.83 to 9.66 Mb in the left and right NILs, respectively (Figure 1-source data 5) . The left and right NILs recapitulate 70.6% and 81.9% of the effect size difference between N2 and CB4856 as measured by Cohen's F, respectively (Cohen, 2013) , which exceeds our observations the linkage mapping results where the QTL on chromosome II explained 63.4% of the total phenotypic variation in the RIAIL population. This discrepancy was observed likely because the NILs are a more homogenous genetic background, and the experiment was performed at higher replication than the linkage mapping. We observed similar levels of phenotypic recapitulation for the four traits used as inputs for the PCA (brood size: 57.8% and 87.4%, animal length: 98.5% and 100%; 69.5% and 68.1%; fluorescence: 58.5% and 64.2% for the left and right NILs). Taken together, these results suggested that genetic differences between N2 and CB4856 within 7.83 to 8.02 Mb on chromosome II conferred resistance to arsenic trioxide.
In parallel to the linkage-mapping approach described above, we performed a genome-wide association (GWA) mapping experiment by quantifying the responses to arsenic trioxide for 86 wild C. elegans strains (Figure 2 -figure supplement 1-source data 1) (Andersen et al., 2012) . Consistent with previous experiments, the PC1 trait was influenced less by the brood size trait, as indicated . However, we noted that the brood size trait did not map to a significant QTL with the GWA mapping approach, which is most likely due to the lower statistical power of this approach. Interestingly, the genomic estimates of broad-and narrow-sense heritability (H 2 ; h 2 ) were low for all of the wild isolates measured and principal component traits (Figure 2-figure supplement 2; Figure 2 -source data 2), which could be because the center of chromosome II has not experienced the chromosome-scale selective sweeps (Andersen et al., 2012) that contribute to much of the population structure within the species. The marker found to be most correlated with the PC1 trait from GWA mapping (II:7,931,252), explains 84.6% of the total heritable phenotypic variation. In addition to the PC1 trait, three of the four measured traits also mapped to significant QTL on the center of chromosome II. ( The following source data and figure supplements are available for figure 2:
Source data 1. supplement 1-source data 1). Notably, the CB4856 strain, which was one of the parents used to construct the RIAIL panel used for linkage mapping, had the non-reference genotype at the marker most correlated with PC1 ( Figure 2B ), suggesting that the same genetic variant(s) might be contributing to the differential arsenic trioxide response between the RIAIL and wild isolate populations.
To fine map the PC1 QTL, we focused on variants from the C. elegans whole-genome variation dataset (Cook et al., 2016 ) that are shared among at least 5% of the 86 wild isolates exposed to arsenic trioxide. Under the assumption that the linkage and GWA mapping QTL are caused by the same genetic variation, we only considered variants present in the CB4856 strain. Eight markers within the QTL region are in complete linkage disequilibrium with each other and are most correlated with the PC1 trait (Figure 2-figure supplement 2; Figure 2 -source data 1). Only one of these markers is located within an annotated gene (dbt-1) and is predicted to encode a cysteine-toserine variant at position 78 (C78S). Although it is possible that the causal variant underlying differential arsenic trioxide response in the C. elegans population is an intergenic variant, we focused on the DBT-1(C78S) variant as a candidate to test for an effect on arsenic response.
A cysteine-to-serine variant in DBT-1 contributes to arsenic response variation
The C. elegans dbt-1 gene encodes the E2 component of the branched-chain a-keto acid dehydrogenase complex (BCKDH) (Jia et al., 2016) . The BCKDH complex is a core component of branchedchain amino acid (BCAA) catabolism and catalyzes the irreversible oxidative decarboxylation of amino-acid-derived branched-chain a-ketoacids (Adeva-Andany et al., 2017). The BCKDH complex belongs to a family of a-ketoacid dehydrogenases that include pyruvate dehydrogenase (PDH) and a-ketoglutarate dehydrogenase (KGDH) (Bergquist et al., 2009) . All three of these large enzymatic complexes include a central E2 component that is lipoylated at one critical lysine residue (two residues in PDH). The function of these enzymatic complexes depends on the lipoylation of these lysine residues (Bergquist et al., 2009; Reed and Hackert, 1990) . In C. elegans, the putative lipoylated lysine residue is located at amino acid position 71 of DBT-1, which is in close proximity to the C78S residue that we found to be highly correlated with arsenic trioxide resistance.
To confirm that the C78S variant in DBT-1 contributes to differential arsenic trioxide responses, we used CRISPR-Cas9-mediated genome editing to generate allele-replacement strains by changing the C78 residue in the N2 strain to a serine and the S78 residue in the CB4856 strain to a cysteine. When treated with arsenic trioxide, the N2 DBT-1(S78) allele-replacement strain recapitulated 56.4% of the phenotypic difference between the CB4856 and N2 strains as measured with the first principal component (Cohen's F) (Cohen, 2013) (Figure 3; Figure 1-source data 4) . Similarly, the CB4856 DBT-1(C78) allele-replacement strain recapitulated 64.8% of the total phenotypic difference between the two parental strains. The degree to which the allele-replacement strains recapitulated the difference in the PC1 trait between the N2 and CB4856 strains matched our observations from the linkage mapping experiment, where the chromosome II QTL explained 63.4% of the total phenotypic variation in the RIAIL population. This result suggested that the majority of heritable variation in arsenic trioxide response was explained by the DBT-1(C78S) allele. We obtained similar results for the BIOSORT-quantified traits ( Figure 1 -source data 4). These results suggested that additional genetic variants between the N2 and CB4856 strains might interact with the DBT-1(C78S) allele to affect different aspects of physiology. Nevertheless, these results functionally validated that the DBT-1 C78S variant underlies differences in physiological responses to arsenic trioxide. Figure 3 . The DBT-1(C78S) variant contributes to arsenic trioxide responses. Tukey box plots of the first principal component generated by PCA on allele-replacement strainphenotypes measured by the COPAS BIOSORT 1000 mM arsenic trioxide exposure are shown (N2,orange; CB4856, blue; allele replacement strains, gray). Labels correspond to the genetic backgroundand the corresponding residue at position 78 of DBT-1 (C for cysteine, S for serine). All pair-wise comparisons are significantly different (Tukey HSD, p-value < 1E-7). DOI: https://doi.org/10.7554/eLife.40260.046 The following figure supplements are available for figure 3: Arsenic trioxide inhibits the DBT-1 C78 allele Mono-methyl branched chain fatty acids (mmBCFA) are an important class of molecules that are produced via BCAA catabolism (Kniazeva et al., 2004; Jia et al., 2016; Kniazeva et al., 2008; Baugh, 2013) . The production of mmBCFA requires the BCKDH, fatty acid synthase (FASN-1), acetyl-CoA carboxylase (POD-2), fatty acyl elongases (ELO-5/6), b-ketoacyl dehydratase (LET-767), and acyl CoA synthetase (ACS-1) (Kniazeva et al., 2004; Jia et al., 2016; Kniazeva et al., 2008; Watts and Ristow, 2017; Entchev et al., 2008; Zhu et al., 2013) . Strains that lack functional elo-5, elo-6, or dbt-1 produce less C15ISO and C17ISO mmBCFAs, arrest at the L1 larval stage, and can be rescued by supplementing the growth media with C15ISO or C17ISO (Kniazeva et al., 2004; Jia et al., 2016; Kniazeva et al., 2008) (Figure 4A ).
Because DBT-1 is involved in BCAA catabolism, we hypothesized that the DBT-1(C78S)-dependent difference in progeny length between the N2 and CB4856 strains after arsenic trioxide treatment might be caused by differential larval arrest through depletion of downstream mmBCFAs. To test this hypothesis, we quantified the abundance of the monomethyl-branched (ISO) and straightchain (SC) forms of C15 and C17 in the N2, CB4856, and allele-replacement genetic backgrounds. We measured the metabolite levels in staged L1 animals and normalized the detected amounts of C15ISO and C17ISO relative to the abundances of C15SC and C17SC, respectively, to mitigate the confounding effects of differences in developmental rates that could be caused by genetic background differences after arsenic trioxide exposure. Generally, the ratios of C15ISO/C15SC and C17ISO/C17SC were reduced in arsenic-treated animals relative to controls ( Figure 4B ; Figure 4 source datas 1-3).
However, arsenic trioxide treatment had a 7.6-fold stronger effect on the C15ISO/C15SC ratio in N2, which naturally has the C78 allele, than on the N2 DBT-1(S78) allele replacement strain. This difference suggests that the DBT-1(C78) allele is more strongly inhibited by arsenic trioxide (0.04 to 0.004, Tukey HSD p-value=0.0358, n = 6). Similarly, we observed a 6.6-fold arsenic-induced reduction in the C17ISO/C17SC ratio when comparing the N2 DBT-1(C78) and N2 DBT-1(S78) strains (Tukey HSD p-value=0.003747, n = 6). When comparing the CB4856 DBT-1(S78) and CB4856 DBT-1 (C78) strains, we observed a 2.8-fold lower C15ISO/C15SC ratio (Tukey HSD p-value=0.0427733, n = 3) and 1.5-fold lower C17ISO/C17SC ratio (Tukey HSD p-value=0.164721, n = 3) in the in the CB4856 DBT-1(C78) strain. We noted that the C17ISO/straight-chain ratio difference was not significantly different between the two CB4856 genetic background strains. However, we observed a significant arsenic-induced decrease in raw C17ISO production in the CB4856 DBT-1(C78) strain (Tukey HSD p-value=0.029) and no significant difference in the CB4856 DBT-1(S78) strain (Tukey HSD p-value=0.1) (Figure 4-figure supplement 1) . Importantly, these DBT-1(C78S) allele-specific reductions in ISO/straight-chain ratios were not caused by arsenic-induced differences in straight-chain fatty acids (Figure 4-figure supplement 2) . These results explained the majority of the physiological differences between the N2 and CB4856 strains in the presence of arsenic trioxide ( Figure 3) and suggested that the DBT-1(C78) allele was inhibited by arsenic trioxide more strongly than DBT-1 (S78). Taken together, the differential reduction in branched-chain fatty acids likely underlies the majority of physiological differences between the sensitive and resistant C. elegans strains.
In addition to arsenic-induced differences in branched chain fatty acid production, we observed significant differences in branched/straight-chain ratios between the parental and allele replacement strains when L1 larval animals were grown in control conditions (Figure 4-figure supplement 3 ; Figure 4 -source datas 1-3). Strains with the DBT-1(C78) had higher ISO/SC ratios relative to strains with the DBT-1(S78) for the C17 (CB4856 DBT-1(C78): Tukey HSD p-value=0.0342525, n = 3; N2 DBT-1(C78): Tukey HSD p-value=0.0342525, n = 6) and C15 ratios (CB4856: Tukey HSD p-value=0.0168749, n = 3; N2: Tukey HSD p-value=0.1239674, n = 6) (Figure 4-figure supplement 3; Figure 4 -source datas 1-3). We noted that the C15ISO/straight-chain ratio was not significantly different when comparing the N2 and N2 allele replacement strain, but the direction of effect matched our other observations, and we saw significant differences in C15ISO levels (N2-C15ISO DBT-1(C78): Tukey HSD p-value=0.0265059, n = 6, Figure 4 -figure supplement 4; Figure 4 source datas 1-3). Importantly, the DBT-1 allele-specific differences in the fatty acid ratio and ISO measurements were not caused by differences in straight-chain fatty acids ( together, these results suggest that the DBT-1(C78) allele produces more branched chain fatty acids than the DBT-1(S78) allele, but this effect was dependent on the developmental stage of the animals.
To test the hypothesis that differential arsenic-induced depletion of branched-chain fatty acids in strains with the DBT-1(C78S) causes physiological differences in growth, we tested if mmBCFA supplementation could rescue the effects of arsenic trioxide-induced toxicity. We exposed the parental and the DBT-1 allele-replacement strains to media containing arsenic trioxide alone, C15ISO alone, or a combination of arsenic trioxide and C15ISO. In agreement with previous experiments, the PC1 trait was more strongly correlated with the animal length, optical density, and fluorescence traits than the brood size trait ( the difference between the C17 ratios for these two strains is not (Tukey HSD p-value = 0.164721). The difference between the C15and C17 ratios for the N2-N2 allele replacement comparisons are both significant (C15: Tukey HSD p-value = 0.0358; C17: Tukey HSD p-value = 0.003747). (C) Tukey box plots median animal length after arsenic trioxide or arsenic trioxide and 0.64 mM C15ISO exposure are shown (N2, orange; CB4856, blue; allele replacement strains, gray). Labels correspond to the genetic background and the corresponding residue at position 78 of DBT-1 (C for cysteine, S for serine). Every pair-wise strain comparison is significant except for the N2 DBT-1(S78) -CB4856 comparisons (Tukey's HSD p-value < 1.43E-6). DOI: https://doi.org/10.7554/eLife.40260.049
The following source data and figure supplements are available for figure 4:
Source data 1. Metabolite measurements for the CB4856 and CB4856 allele replacement strains (Used for Figure 4B and Figure 4 -figure supplement 1-3). DOI: https://doi.org/10.7554/eLife.40260.062 Source data 2. Processed metabolite measurements for the CB4856 and CB4856 allele replacement strains (Used for Figure 4B and Figure 4 - figure  supplement 1-3) . DOI: https://doi.org/10.7554/eLife.40260.063 Source data 3. Metabolite measurements for the N2 and N2 allele replacement strains (Used for Figure 4B and C15ISO supplementation of the arsenic growth media caused a 53.5% rescue of the allele-specific effect in the N2 genetic background (Figure 4-figure supplement 6) . Similarly, when arsenicexposed CB4856 DBT-1(C78) animals were supplemented with C15ISO, the allele-specific PC1 phenotypic difference was reduced by 25.6% when compared to the difference between the CB4856 DBT-1(C78) and CB4856 DBT-1(S78) strains in arsenic trioxide alone (Figure 4-figure supplement  6C ). By contrast, CB4856 DBT-1(S78) and N2 DBT-1(S78) phenotypes were unaffected by C15ISO supplementation in arsenic trioxide media. We observed similar trends for the animal length, optical density, and fluorescence traits that we used as inputs for PCA but not for brood size (Figure 4-figure supplement 9C) . Collectively, these data support the hypothesis that the cysteine/serine variant in DBT-1 contributes to arsenic sensitivity in C. elegans by reducing ISO fatty acid biosynthesis, and the DBT-1(C78) variant can be partially rescued by supplementation with mmBCFAs.
Arsenic exposure increases mmBCFA production and favors a cysteine allele in human DBT1
To test whether our results from C. elegans translate to human variation in arsenic sensitivity, we tested the role of DBT1 variation on arsenic trioxide responses and mmBCFA biosynthesis in human cells. The human DBT1 enzyme contains a serine at position 112 that corresponds to the C78 residue in C. elegans DBT-1 (Figure 4-figure supplement 6 ). Using CRISPR-Cas9, we edited batch cultures of 293 T cells to generate a subset of cells with DBT1(S112C). These cells were exposed to arsenic trioxide or control conditions, and we monitored changes in the fraction of cells carrying the DBT1 (C112) allele. We found that arsenic exposure caused a 4% increase in the fraction of cells that contained the DBT1(C112) allele ( Figure 5B , Fisher's exact test, p-value<1.9E-16; Figure 5 -source datas 1-2). Though the human DBT1 does not vary within the human population at S112, two residues in close spatial proximity to S112 do vary among individuals in the population (R113C and W84C) ( Figure 5A ) (Forbes et al., 2008) . To test the effects of these residues on arsenic trioxide sensitivity, we performed the same editing and arsenic selection procedure described above. Over the course of the selection experiment, cells with DBT1(W84C) and DBT1(R113C) increased by 2% and 1%, respectively ( Figure 5B) . Therefore, it appears that all three missense variants caused a slight increase in fitness in batch-edited human cell cultures exposed to arsenic -the opposite result we found in C. elegans. To determine if branched-chain fatty acid production was altered by arsenic exposure, as we found in C. elegans, we measured mmBCFA production in unedited 293 T cells in arsenic and mock-treated cultures. We found that overall fatty acid production was markedly reduced in arsenic-treated cultures. In contrast to our observations in C. elegans, straight-chain fatty acids were more drastically reduced than ISO fatty acids ( Figure 5 -source data 3), suggesting pleiotropic effects and a general perturbation of fatty acid metabolism.
Discussion
In this study, we characterized the effects of C. elegans natural genetic variation on physiological responses to the pervasive environmental toxin arsenic trioxide. Though the effects of this toxin have been extensively studied in a variety of systems (Ratnaike, 2003; Mandal and Suzuki, 2002; Bergquist et al., 2009; Paul et al., 2014; Shen et al., 2013) , recent evidence from human population studies have revealed local adaptations within region-specific subpopulations (Schlebusch et al., 2015; Fujihara et al., 2009; Gomez-Rubio et al., 2010; Li et al., 2017) . Our investigation into the natural variation in C. elegans responses to arsenic trioxide led to the discovery of a novel mechanism by which this compound could elicit toxicity. We show that arsenic trioxide differentially inhibits two natural alleles of the E2 domain of the BCKDH complex, which is encoded by the dbt-1 gene. Specifically, strains with the DBT-1(C78) allele are more sensitive to arsenic trioxide than strains carrying the DBT-1(S78). Furthermore, we show that the increased sensitivity of the DBT-1(C78) allele is largely explained by differences in the production of mmBCFAs ( Figure 4B-C) , which are critical molecules for developmental progression beyond the first larval stage. Arsenic is thought to inhibit the activity of both the pyruvate dehydrogenase (PDH) and the a-ketoglutarate (KGDH) dehydrogenase complexes through interactions with the reduced form of lipoate (Bergquist et al., 2009) , which is the cofactor for the E2 domain of these complexes. Like the PDH and KGDH complexes, the E2 domain of BCKDH complex requires the cofactor lipoate to perform its enzymatic function (Pettit et al., 1978; Heffelfinger et al., 1983; Yeaman, 1989) . The inhibition of DBT-1 by arsenic trioxide could involve three-point coordination of arsenic by the C78 thiol and the reduced thiol groups of the nearby lipoate. However, based on the crystal structure (PDB:1Y8N), the atomic distance between the C78 thiol group and the thiol groups from the lipoylated lysine is~32 Å , which might be too far for coordinating arsenic ( Figure 5-figure supplement 1 ) (Kato et al., 2005) . Alternatively, arsenic trioxide could inhibit DBT-1(C78) through coordination between the thiol groups of C78 and C65 (~8.5 Å ) ( Figure 5-figure supplement 1) . Analogous thiol-dependent mechanisms have been proposed for the inhibition of other enzymes by arsenic . Despite structural similarities and a shared cofactor, no evidence in the literature indicates that BCKDH is inhibited by arsenic trioxide, so these results demonstrate the first connection of arsenic toxicity to BCKDH E2 subunit inhibition.
Multiple sequence alignments show that cysteine residues C65 and C78 of C. elegans DBT-1 correspond to residues S112 and C99 of human DBT1 ( Figure 5A ). Although DBT1 does not vary at position 112 within the human population, two residues (R113C and W84C) in close spatial proximity do (Forbes et al., 2008) . We hypothesized that cysteine variants in DBT1 would sensitize human cells to arsenic trioxide. However, we found that the cysteine variants (W84C, S112C, and R113C) proliferated slightly more rapidly than the parental cells in the presence of arsenic. Notably, a growing body of evidence suggests that certain cancer cells upregulate components involved in BCAA metabolism, and this upregulation promotes tumor growth (Burrage et al., 2014; Tö njes et al., 2013) . Perhaps, the increased proliferation of human cell lines that contain the DBT1 C112 allele ( Figure 5 ) is caused by increased activity of the BCKDH complex. It is worth noting that human cell lines grown in culture do not have the same strict requirements for mmBCFA, and the requirements for different fatty acids are variable among diverse immortalized cell lines (Hughes-Fulford et al., 2001; Agostini et al., 2004) . Furthermore, in C. elegans, the developmental defects associated with dbt-1 loss-of-function can be rescued by neuronal-specific expression of dbt-1 (Jia et al., 2016) , suggesting that the physiological requirements of mmBCFA in C. elegans depend on the coordination of multiple tissues that cannot be recapitulated with cell-culture experiments. These results further highlight the complexity of arsenic toxicity, as well as the physiological requirements for BCAA within and across species and could explain the discrepancy between the physiological effects we observed in C. elegans and human cell-line experiments. Given that arsenic trioxide has become the standard-of-care for treating APL (Coombs et al., 2015) and is gaining traction in treating other leukemias, it might be important to further explore the effects of arsenic on BCAA metabolism and cancer growth.
The C78 allele of DBT-1 is likely the derived allele in the C. elegans population because all other organisms have a serine at the corresponding position. The loss of the serine allele in the C. elegans population might have been caused by relaxed selection at this locus, although this hypothesis is difficult to test because of the effects of linked selection and decreased recombination in chromosome centers. It is hypothesized that the C. elegans species originated from the Pacific Rim and that the ancestral state more closely resembles the CB5846 strain than the N2 strain (Andersen et al., 2012; Thompson et al., 2015) . The CB4856 strain was isolated from the Hawaiian island of O'ahu (Hodgkin and Doniach, 1997) , where environments could have elevated levels of arsenic in the soil from volcanic activity, the farming of cane sugar, former construction material (canec) production facilities, or wood treatment plants (Hawaii.gov). It is possible that as the C. elegans species spread across the globe into areas with lower levels of arsenic in the soil and water, the selective pressure to maintain high arsenic tolerance was relaxed and the cysteine allele appeared. Alternatively, higher mmBCFA levels at the L1 larval stage in strains with the DBT-1(C78) allele (Figure 4 -figure supplements 3-4) might cause faster development in certain conditions, although we did not observe allele-specific growth differences in laboratory conditions. Despite these clues suggesting selection in local environments, the genomic region surrounding the dbt-1 locus does not show a signature of selection as measured by Tajima's D (Tajima, 1989) ( 
Materials and methods
Strains
Animals were fed the bacterial strain OP50 and grown at 20˚C on modified nematode growth medium (NGM), containing 1% agar and 0.7% agarose to prevent burrowing of the wild isolates (Boyd et al., 2012) . For each assay, strains were grown for five generations with no strain entering starvation or encountering dauer-inducing conditions . Wild C. elegans isolates used for genome-wide association and recombinant inbred advanced intercross lines (RIAILs) used for linkage mapping have been described previously (Cook et al., 2016; Cook et al., 2017; Andersen et al., 2015) . Strains constructed for this manuscript are listed above in the Key Resources Table. High-throughput fitness assay
We used the high-throughput fitness assay (HTA) described previously . In short, strains are passaged for four generations before bleach-synchronization and aliquoted to 96-well microtiter plates at approximately one embryo per microliter in K medium (Boyd et al., 2012) . The final concentration of NaCl in the K medium for the genome-wide association (GWA) and linkage mapping assays was 51 mM. For all subsequent experiments the final NaCl concentration was 10.2 mM. The following day, hatched and synchronized L1 animals were fed HB101 bacterial lysate (Pennsylvania State University Shared Fermentation Facility, State College, PA, [García-González et al., 2017] ) at a final concentration of 5 mg/ml and grown for two days at 20˚C. Next, three L4 larvae were sorted using a large-particle flow cytometer (COPAS BIOSORT, Union Biometrica, Holliston, MA) into microtiter plates that contain HB101 lysate at 10 mg/ml, K medium, 31.25 mM kanamycin, and either arsenic trioxide dissolved in 1% water or 1% water alone. The animals were then grown for four days at 20˚C. For linkage mapping and GWA mapping experiments, we added polychromatic fluorescent beads (Polysciences, cat. #19507-5) to each well for five minutes. The populations were treated with sodium azide (50 mM) prior to being measured with the BIO-SORT. To reduce experimental costs, the polychromatic fluorescent beads were not added to follow-up experiments. For all experiments, we report the results for four independently quantified traits): the normalized brood size (norm.n), mean progeny length per well (mean.TOF), the mean optical density normalized by animal length per well (mean.norm.EXT), and the mean fluorescence normalized by animal length per well (mean.norm.yellow). All raw experimental data can be found on FigShare (https://doi.org/10.6084/m9.figshare.7458980.v2).
Calculation of fitness traits for genetic mappings
Phenotype data generated using the BIOSORT were processed using the R package easysorter, which was specifically developed for processing this type of data (Shimko and Andersen, 2014) . Briefly, the function read_data, reads in raw phenotype data and runs a support vector machine to identify and eliminate bubbles. Next, the remove_contamination function eliminates any wells that were identified as contaminated prior to scoring population parameters. This analysis results in processed BIOSORT data where each observation is for a given strain corresponds to the measurements for an individual animal. However, the phenotypes we used for mapping and follow-up experiments are summarized statistics of populations of animals in each well of a 96-well plate. The sumplate function was used to generate summary statistics of the measured parameters for each animal in each well. These summary statistics include the 10th, 25th, 50th, 75th, and 90th quantiles for time of flight (TOF), animal extinction (EXT), and three fluorescence channels (Green, Yellow, and Red), which correspond to animal length, optical density, and ability to pump fluorescent beads, respectively. Measured brood sizes (n) are normalized by the number of animals that were originally sorted into each well (norm.n). For mapping experiments, a single well replicate for each strain is summarized using the sumplate function. For follow-up experiments, multiple replicates for each strain indicated by a unique plate, well, and column were used. After summary statistics for each well are calculated, we accounted for differences between assays using the regress(assay = TRUE) function in the easysorter package. Outliers in the GWA and linkage mapping experiments were identified and eliminated using the bamf_prune function in easysorter. For follow-up experiments that contained multiple replicates for each strain, we eliminated strain replicates that were more than two standard deviations from the strain mean for each condition tested. Finally, arsenic-specific effects were calculated using the regress(assay = FALSE) function from easysorter, which accounts for strain-specific differences in growth parameters present in control conditions.
Principal component analysis of processed BIOSORT measured traits
The COPAS BIOSORT measures individual animal length (TOF), optical density (EXT), fluorescence (green, yellow, and red). We use these data to calculate the total number of animals in a well and then normalize by the number of animals initially sorted into the well (brood size). All these measurements were then summarized using the easysorter package to generate various summary statistics of each measured parameter, including five distribution quantiles and measures of dispersion . We used four independently quantified traits as inputs to principal component analysis (PCA): the normalized brood size (norm.n), mean progeny length per well (mean.TOF), the mean optical density normalized by animal length per well (mean.norm.EXT), and the mean fluorescence normalized by animal length per well (mean.norm.yellow). Although we only used fluorescent beads in the GWA and linkage mapping experiments, we found that fluorescence-based traits exhibited an arsenic-specific effect that correlated with strain sickness. Prior to principal component analysis (PCA), HTA phenotypes were scaled to have a mean of zero and a standard deviation of one using the scale function in R. PCA was performed using the prcomp function in R (R Development Core Team, 2017). Eigenvectors were subsequently extracted from the object returned by the prcomp function.
Arsenic trioxide dose-response assays
All dose-response experiments were performed on four genetically diverged strains (N2, CB4856, DL238, and JU775) in technical quadruplicates prior to performing GWA and linkage mapping experiments (Figure 1 -source data 1). Animals were assayed using the HTA, and phenotypic analyses were performed as described above. The arsenic trioxide concentration for GWA and linkage mapping experiments was chosen based on an observable effect for animal length and brood size phenotypes in the presence of arsenic.
Heritability calculations
For dose-response experiments, broad-sense heritability (H 2 ) estimates were calculated using the lmer function in the lme4 package with the following linear mixed model (phenotype~1 + (1|strain)) (Bates et al., 2014) . H 2 was then calculated as the fraction of the total variance that can be explained by the random component (strain) of the mixed model. Prior to estimating H 2 ; we removed outlier replicates that we defined as replicates with values greater than two standard deviations away from the mean phenotype. Outliers were defined on a per-trait and per-strain basis. Heritability estimates for dose response experiments are in Figure 1 -figure supplement 3-source data 1.
Heritability estimates for the linkage mapping experiment were calculated using two approaches. In both approaches, we used the previously described RIAIL genotype matrix to compute relatedness matrices (Andersen et al., 2012) . In the first approach, a variance component model using the R package regress was used to estimate the fraction of phenotypic variation explained by additive and epistatic genetic factors, H 2 , or just additive genetic factors, h 2 David Clifford, 2006) , using the formula (y~1,~ZA+ZAA), where y is a vector of RIAIL phenotypes, ZA is the additive relatedness matrix, and ZAA is the pairwise-interaction relatedness matrix. The additive relatedness matrix was calculated as the correlation of marker genotypes between each pair of strains. In addition, a two-component variance model was calculated with both an additive and pairwise-interaction effect. The pairwise-interaction relatedness matrix was calculated as the Hadamard product of the additive relatedness matrix.
The second approach utilized a linear mixed model and the realized additive and epistatic relatedness matrices (Endelman, 2011; Covarrubias-Pazaran, 2016; Su et al., 2012; Endelman and Jannink, 2012) . We used the mmer function in the sommer package with the formula (y~A + E) to estimate variance components, where y is a vector of RIAIL phenotypes, A is the realized additive relatedness matrix, and E is the epistatic relatedness matrix. This same approach was used to estimate heritability for the GWA mapping phenotype data, with the only difference being that we used the wild isolate genotype matrix described below. Heritability estimates for RIAIL and wild isolate data are in Figure 1 -figure supplement 6-source data 1 and Figure 2 -figure supplement 5-source data 1, respectively.
Effect size calculations for dose response assay
We first fit a linear model with the formula (phenotype~strain) for all measured and principal component traits for each concentration of arsenic trioxide using the lm R function. Next, we extracted effect sizes using the anova_stats function from the sjstats R package (Lüdecke, 2018) . Effect sizes for dose responses are in Figure 1 -figure supplement 3-source data 2.
Linkage mapping
A total of 262 RIAILs were phenotyped in the HTA described previously for control and arsenic trioxide conditions . The phenotype and genotype data were entered into R and scaled to have a mean of zero and a variance of one for linkage analysis (Figure 1-source data 2) . Quantitative trait loci (QTL) were detected by calculating logarithm of odds (LOD) scores for each marker and each trait as Àn ln 1 À r 2 ð Þ=2ln 10 ð Þ ð Þ, where r is the Pearson correlation coefficient between RIAIL genotypes at the marker and phenotype trait values (Bloom et al., 2013) . The maximum LOD score for each chromosome for each trait was retained from three iterations of linkage mappings (Figure 1-source data 3) . We randomly permuted the phenotype values of each RIAIL while maintaining correlation structure among phenotypes 1000 times to estimate the significance threshold empirically. The significance threshold was set using a genome-wide error rate of 5%. Confidence intervals were defined as the regions contained within a 1.5 LOD drop from the maximum LOD score (Broman et al., 2003) .
Near-isogenic line (NIL) generation
NILs were generated by crossing N2xCB4856 RIAILs to each parental genotype. For each NIL, eight crosses were performed followed by six generations of selfing to homozygose the genome. Reagents used to generate NILs are detailed in the Key Resources Table. The NILs responses to 1000 mM arsenic trioxide were quantified using the HTA described above (Figure 1-source data  4) . NIL whole-genome sequencing and analysis was performed as described previously (Brady et al., 2018) (Figure 1-source data 5 ).
Genome-wide association mapping
Genome-wide association (GWA) mapping was performed using phenotype data from 86 C. elegans isotypes (Figure 2-source data 2) . Genotype data were acquired from the latest VCF release (Release 20180527) from CeNDR that was imputed as described previously . We used BCFtools (Li, 2011) to filter variants that had any missing genotype calls and variants that were below 5% minor allele frequency. We used PLINK v1.9 (Purcell et al., 2007; Chang et al., 2015) to LD-prune the genotypes at a threshold of r 2 <--indep-pairwise 50 10 0.8.0.8, using -indep-pairwise 50 10 0.8. This resulting genotype set consisted of 59,241 markers that were used to generate the realized additive kinship matrix using the A.mat function in the rrBLUP R package (Endelman, 2011) (Figure 2 -source data 3). These markers were also used for genome-wide mapping. However, because these markers still have substantial LD within this genotype set, we performed eigen decomposition of the correlation matrix of the genotype matrix using eigs_sym function in Rspectra package (Qiu, 2018) . The correlation matrix was generated using the cor function in the correlateR R package (Bilgrau, 2018) . We set any eigenvalue greater than one from this analysis to one and summed all of the resulting eigenvalues (Li and Ji, 2005) . This number was 500.761, which corresponds to the number of independent tests within the genotype matrix. We used the GWAS function in the rrBLUP package to perform genome-wide mapping with the following command: rrBLUP::GWAS (pheno = PC1, geno = Pruned_Markers, K = KINSHIP, min.MAF = 0.05, n.core = 1, P3D = FALSE, plot = FALSE) . To perform fine-mapping, we defined confidence intervals from the genome-wide mapping as +/-100 SNVs from the rightmost and leftmost markers above the Bonferroni significance threshold. We then generated a QTL region of interest genotype matrix that was filtered as described above, with the one exception that we did not perform LD pruning. We used PLINK v1.9 to extract the LD between the markers used for fine mapping and the peak QTL marker identified from the genome-wide scan. We used the same command as above to perform fine mapping, but with the reduced variant set. The workflow for performing GWA mapping can be found on https://github.com/AndersenLab/cegwas2-nf (copy archived at https://github.com/ elifesciences-publications/cegwas2-nf; Zdraljevic et al., 2019) . All trait mapping results can be found on FigShare (https://doi.org/10.6084/m9.figshare.7828706.v1).
Generation of dbt-1 allele replacement strains
Allele replacement strains were generated using CRISPR-Cas9-mediated genome editing, using the co-CRISPR approach (Kim et al., 2014) with Cas9 ribonucleoprotein delivery (Paix et al., 2015) . Alt-R crRNA and tracrRNA were purchased from IDT (Skokie, IL). tracrRNA (IDT, 1072532) was injected at a concentration of 13.6 mM. The dpy-10 and the dbt-1 crRNAs were injected at 4 mM and 9.6 mM, respectively. The dpy-10 and the dbt-1 single-stranded oligodeoxynucleotides (ssODN) repair templates were injected at 1.34 mM and 4 mM, respectively. Cas9 protein (IDT, 1074182) was injected at 23 mM. To generate injection mixes, the tracrRNA and crRNAs were incubated at 95˚C for 5 min and 10˚C for 10 min. Next, Cas9 protein was added and incubated for 5 min at room temperature. Finally, repair templates and nuclease-free water were added to the mixtures and loaded into pulled injection needles (1B100F-4, World Precision Instruments, Sarasota, FL). Individual injected P 0 animals were transferred to new 6 cm NGM plates approximately 18 hr after injections. Individual F 1 rollers were then transferred to new 6 cm plates to generate self-progeny. The region surrounding the desired S78C (or C78S) edit was then amplified from F 1 rollers using primers oECA1163 and oECA1165. The PCR products were digested using the SfcI restriction enzyme (R0561S, New England Biolabs, Ipswich, MA). Differential band patterns signified successfully edited strains because the N2 S78C, which is encoded by the CAG codon, creates an additional SfcI cut site. Non-Dpy, non-Rol progeny from homozygous edited F 1 animals were propagated. If no homozygous edits were obtained, heterozygous F 1 progeny were propagated and screened for the presence of the homozygous edits. F 1 and F 2 progeny were then Sanger sequenced to verify the presence of the proper edited sequence. The phenotypes of allele replacement strains in control and arsenic trioxide conditions were measured using the HTA described above (Figure 1-source  data 4) . PCA phenotypes for allele-replacement strains were generated the same way as described above for GWA mapping traits and are located in Figure 1 -source data 4.
Rescue with 13-methyltetradecanoic acid Strains were grown as described for a standard HTA experiment. In addition to adding arsenic trioixde to experimental wells, we also added a range of C15iso (13-methyltetradecanoic acid, Matreya Catalog # 1605) concentrations to assay rescue of arsenic effects (Figure 4 -source data 4).
Growth conditions for metabolite profiling
For L1 larval stage assays, chunks (~1 cm) were taken from starved plates and placed on multiple fresh 10 cm plates. Prior to starvation, animals were washed off of the plates using M9, and embryos were prepared by bleach synchronization. Approximately 40,000 embryos were resuspended in 25 ml of K medium and allowed to hatch overnight at 20˚C. L1 larvae were fed 15 mg/ml of HB101 lysate the following morning and allowed to grow at 20˚C for 72 hr. We harvested 100,000 embryos from gravid adults by bleaching. These embryos were hatched overnight in 50 ml of K medium in a 125 ml flask. The following day, we added arsenic trioxide to a final concentration of 100 mM and incubated the cultures for 24 hr. After 24 hr, we added HB101 bacterial lysate (2 mg/ml) to each culture. Finally, we transferred the cultures to 50 ml conical tubes, centrifuged the cultures at 3000 RPM for 3 min to separate the pellet and supernatant. The supernatant and pellets from the cultures were frozen at À80˚C and prepared for analysis. For young adult stage assays, 45,000 animals per culture were prepared as described above but in S medium, at a density of three animals per microliter, and fed HB101 lysate (5 mg/mL). These cultures were shaken at 200 RPM, 20˚C in 50 mL Erlenmeyer flasks for 62 hr. For harvesting, we settled 15 mL of cultures for 15 min at room temperature and then pipetted the top 12 mL of solution off of the culture. The remaining 3 mL of animal pellet was washed with 10 mL of M9, centrifuged at 1000 g for one minute, and then the supernatant removed. This wash was repeated once more with M9 and again with water. The final nematode pellet was snap frozen in liquid nitrogen.
Nematode metabolite extractions
Pellets were lyophilized 18-24 hr using a VirTis BenchTop 4K Freeze Dryer until a chalky consistency was achieved. Dried pellets were transferred to 1.5 mL microfuge tubes and dry pellet weight recorded. Pellets were disrupted in a Spex 1600 MiniG tissue grinder after the addition of three stainless steel grinding balls to each sample. Microfuge tubes were placed in a Cryoblock (Model 1660) cooled in liquid nitrogen, and samples were disrupted at 1100 RPM for two cycles of 30 s. Each sample was individually dragged across a microfuge tube rack eight times, inverted, and flicked five times to prevent clumping. This process was repeated two additional rounds for a total of six disruptions. Pellets were transferred to 4 mL glass vials in 3 mL 100% ethanol. Samples were sonicated for 20 min (on/off pulse cycles of two seconds at power 90 A) using a Qsonica Ultrasonic Processor (Model Q700) with a water bath cup horn adaptor (Model 431C2). Following sonication, glass vials were centrifuged at 2750 RCF for five minutes in an Eppendorf 5702 Centrifuge using rotor F-35-30-17. The resulting supernatant was transferred to a clean 4 mL glass vial and concentrated to dryness in an SC250EXP Speedvac Concentrator coupled to an RVT5105 Refrigerated Vapor Trap (Thermo Scientific). The resulting powder was suspended in 100% ethanol according to its original dry pellet weight: 0.01 mL 100% ethanol per mg of material. The suspension was sonicated for 10 min (pulse cycles of 2 s on and 3 s off at power 90 A) followed by centrifugation at 20,817 RCF in a refrigerated Eppendorf centrifuge 5417R at 4˚C. The resulting supernatant was transferred to an HPLC vial containing a Phenomenex insert (cat #AR0-4521-12) and centrifuged at 2750 RCF for five minutes in an Eppendorf 5702 centrifuge. The resulting supernatant was transferred to a clean HPLC vial insert and stored at À20˚C or analyzed immediately.
Mass spectrometric analysis
Reversed-phase chromatography was performed using a Dionex Ultimate 3000 Series LC system (HPG-3400 RS High Pressure pump, TCC-3000RS column compartment, WPS-3000TRS autosampler, DAD-3000 Diode Array Detector) controlled by Chromeleon Software (ThermoFisher Scientific) and coupled to an Orbitrap Q-Exactive mass spectrometer controlled by Xcalibur software (ThermoFisher Scientific). Metabolites were separated on a Kinetex EVO C18 column, 150 mm x 2.1 mm, particle size 1.7 mm, maintained at 40˚C with a flow rate of 0.5 mL/min. Solvent A: 0.1% ammonium acetate in water; solvent B: acetonitrile (ACN). A/B gradient started at 5% B for 30 s, followed by a linear gradient to 95% B over 13.5 min, then a linear gradient to 100% B over 3 min. 100% B was maintained for 1 min. Column was washed after each run with 5:1 isopropanol:ACN, flow rate of 0.12 mL/min for 5 min, followed by 100% ACN for 2.9 min, a linear gradient to 95:5 water:ACN over 0.1 min, and then 95:5 water:ACN for 2 min with a flow rate of 0.5 mL/min. A heated electrospray ionization source (HESI-II) was used for the ionization with the following mass spectrometer parameters: spray voltage: 3 kV; capillary temperature: 320˚C; probe heater temperature: 300˚C; sheath gas: 70 AU; auxiliary gas flow: 2 AU; resolution: 240,000 FWHM at m/z 200; AGC target: 5e6; maximum injection time: 300 ms. Each sample was analyzed in negative and positive modes with m/z range 200-800. Fatty acids and most ascarosides were detected as [M-H] -ions in negative ionization mode. Peaks of known abundant ascarosides and fatty acids were used to monitor mass accuracy, chromatographic peak shape, and instrument sensitivity for each sample. Processed metabolite measures can be found in Figure 4 -source datas 1-3 and Figure 4 -figure supplement 4-source datas 1 (Artyukhin et al., 2018) .
Statistical analyses
All p-values testing the differences of strain phenotypes in the NIL, allele-replacement, and C15ISO experiments were performed in R using the TukeyHSD function with an ANOVA model with the formula (phenotype~strain). 
CRISPR-Cas9 gene editing in human cells
The 293 T cells were sourced from CCLE. Identity authenticated by SNP profiling. Cells were regularly tested for Mycoplasma (~bimonthly). Gene-editing experiments were performed in a single parallel culture experiment using human 293 T cells (ATCC) grown in DMEM with 10% FBS. On day zero, 300,000 cells were seeded per well in a six-well plate format. The following day, two master mixes were prepared: a) LT-1 transfection reagent (Mirus) was diluted 1:10 in Opti-MEM and incubated for 5 min; b) a DNA mix of 500 ng Cas9-sgRNA plasmid (Supplementary file 1-2) with 250 pmol repair template oligonucleotide was diluted in Opti-MEM in a final volume of 100 mL. 250 mL of the lipid mix was added to each of the DNA mixes and incubated at room temperature for 25 min. Following incubation, the full 350 mL volume of DNA and lipid mix was added dropwise to the cells. These six-well plates were then centrifuged at 1000 x g for 30 min. After 6 hr, the media on the cells was replaced. For the next 6 days, cells were expanded and passaged as needed. On day 7, one million cells were taken from each set of edited and unedited cells and placed into separate T75s with either media-only or 5 mM arsenic-containing media. Days 7 to 14, arsenic and media-only conditions were maintained at healthy cell densities. Days 14 to 18, arsenic exposed cell populations were maintained off arsenic to allow the populations to recover prior to sequencing. Media-only conditions were maintained in parallel. On day 18, all arsenic and media-only conditions were pelleted for genomic DNA extraction.
Analysis of CRISPR-Cas9 editing in human cells
Genomic DNA was extracted from cell pellets using the QIAGEN (QIAGEN, Hilden, Germany) Midi or Mini Kits based on the size of the cell pellet (51183, 51104) according to the manufacturer's recommendations. DBT1 loci were first amplified with 17 cycles of PCR using a touchdown protocol and the NEBnext 2x master mix (New England Biolabs M0541). The resulting product served as input to a second PCR, using primers that appended a sample-specific barcode and the necessary adaptors for Illumina sequencing. The resulting DNA was pooled, purified with SPRI beads (A63880, Beckman Coulter, Brea, CA), and sequenced on an Illumina MiSeq with a 300-nucleotide single-end read with an eight nucleotide index read. For each sample, the number of reads exactly matching the wild-type and edited DBT1 sequence were determined ( Figure 5 -source data 1).
Preparing human cells for mass spectroscopy
Mass spectroscopy experiments used human 293 T cells (ATCC) grown in DMEM with 10% FBS. On day zero, 150,000 cells were seeded into 15 cm tissue cultures dishes with 15 mL of either 2.5 mM arsenic or no arsenic media. Each condition had five replicates. On day 3, the no arsenic cells were approaching confluence and required passaging. Arsenic conditions were at~30% confluence and received a media change. On day seven, both conditions were near confluence, media was removed, and plates were rinsed with ice cold PBS, remaining liquid removed. Plates were frozen at À80˚C before processing for mass spectrometric analysis. Cells were scraped off the plates with PBS and pelleted in microfuge tubes. Cell pellets were lyophilized 18-24 hr using a VirTis BenchTop 4K Freeze Dryer and extracted in 100% ethanol using the same sonication program as described for nematode extraction. Following sonication, samples were centrifuged at 20,817 RCF in a refrigerated Eppendorf centrifuge 5417R at 4˚C. Clarified supernatant was aliquoted to a new tube and concentrated to dryness in an SC250EXP Speedvac Concentrator coupled to an RVT5105 Refrigerated Vapor Trap (Thermo Scientific). The resulting material was suspended in. 1 mL 100% ethanol and analyzed by LC-MS as described. Metabolite measurements can be found in Figure 5 -source data 3.
Tajima's D calculation
We used the VCF corresponding to CeNDR release 20160408 (https://elegansvariation.org/data/ release/20160408) to calculate Tajima's D. Tajima's D was calculated using the tajimas_d function in the cegwas package using default parameters (window size = 500 SNVs, sliding window distance = 50 SNVs, outgroup = N2) ( The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Data availability All data generated or analyzed during this study are included in the manuscript and supporting files.
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